175 related articles for article (PubMed ID: 33100863)
1. IL-18 and related function proteins associated with tuberculosis severity and screening for active TB among patients with non-mycobacterial community-acquired pneumonia (CAP).
Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Druszczynska M
Saudi J Biol Sci; 2020 Nov; 27(11):3035-3045. PubMed ID: 33100863
[TBL] [Abstract][Full Text] [Related]
2. IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.
Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Wlodarczyk M; Druszczynska M
PLoS One; 2019; 14(12):e0225556. PubMed ID: 31821340
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis.
Wawrocki S; Kielnierowski G; Rudnicka W; Seweryn M; Druszczynska M
Pathogens; 2020 Jun; 9(6):. PubMed ID: 32521630
[TBL] [Abstract][Full Text] [Related]
5. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
6. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064
[TBL] [Abstract][Full Text] [Related]
11. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
14. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: A cohort study.
Zhang L; Wan S; Ye S; Cheng X; Zhang Y; Shi X; Zhou B; Sun X; Liu X
Clin Chim Acta; 2019 Dec; 499():64-69. PubMed ID: 31454491
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
[TBL] [Abstract][Full Text] [Related]
16. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
17. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.
Wlodarczyk M; Rudnicka W; Janiszewska-Drobinska B; Kielnierowski G; Kowalewicz-Kulbat M; Fol M; Druszczynska M
PLoS One; 2014; 9(9):e107208. PubMed ID: 25221998
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
20. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
